Location of Repository

Investigation of the molecular genetic basis of molybdenum hydroxylase deficiencies in rats and man

By Joanne Jackson
Topics: QD
OAI identifier: oai:eprints.hud.ac.uk:5958

Suggested articles



  1. (1999). A
  2. (1972). A comparison of the specificities of xanthine oxidase and aldehyde oxidase.
  3. (1971). a). Aldehyde oxidase: catalysis of the oxidation of N1-methynicatinamide and pyridoxal.
  4. (2000). Accelerated publication - Deletion mutation in Drosophila ma-I homologueous, putative molybdopterin cofactor sulfurase gene is associated with bovine xanthinuria type
  5. (1999). Activity of the molybdopterin-containing xanthine dehydrogenase of Rhodobacter capsulatus can be restored by high molybdenum concentrations in a moeA mutant defective in molybdenum cofactor biosynthesis.
  6. (1999). Aldehyde oxidase-dependent marked species difference in hepatic metabolism of the sedative-hypnotic, Zaleplon, between monkeys and rats.
  7. (1995). Analysis of aldehyde oxidase and xanthine dehydrogenase oxidase as possible candidate genes for autosomal recessive familial amyotrophic-lateral-sclerosis.
  8. (1994). Assignment of human xanthine dehydrogenase gene to chromosome 2p22.
  9. (1993). cDNA cloning, characterization, and tissue-specific expression of human xanthine dehydrogenase xanthine-oxidase.
  10. (1999). cDNA cloning, sequencing, and characterization of male and female rat liver aldehyde oxidase (rAOXI) - Differences in redox status may distinguish male and female forms of hepatic
  11. (1996). Cloning and expression in vitro of human xanthine dehydrogenase oxidase.
  12. (1995). Cloning and molecular characterization of Hxa, the gene coding for the xanthine dehydrogenase (purine hydroxylasc-1) of Aspergillus-nidulans.
  13. (1993). Cloning of the cDNA-encoding human xanthine dehydrogenase (oxidase) - structural-analysis of the protein and chromosomal location of the gene.
  14. (2000). Cloning of the cDNAs coding for two novel molybdo-flavoproteins showing high similarity with aldehyde oxidase and xanthine oxidoreductase.
  15. (1998). Comparative localization of aldehyde oxidase and xanthine oxidoreductase activity in rat tissues.
  16. (1997). Comparison of oxygen radical generation from the reductive activation of doxorubicin, streptonigin, and menadione by xanthine oxidase and xanthine dehydrogenase.
  17. (2000). Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversion.
  18. (2002). Crystal structures of the active and alloxanthine-inhibited forms of xanthine dehydrogenase from Rhodobacter capsulatus.
  19. (1995). Crystal-structure of the xanthine oxidasc-related aldehyde oxidoreductase from D. -gigas.
  20. (1999). Cytochrome P450-null mice.
  21. (2001). Cytosolic xanthine oxidoreductase mediated bioactivation of ethanol to acetaldehyde and free radicals in rat breast tissue. Its potential role in alcohol-promoted mammary cancer.
  22. (1988). Deficiency in bilirubin UDP-glucuronyl transferase as a genetic determinant of acetaminophen toxicity.
  23. (2001). Determination of xanthine oxidoreductase forms: influence of reaction conditions.
  24. (2000). Distribution of the Moenzymes aldehyde oxidase, xanthine dehydrogenase and nitrate reductase in maize (Zea mays L. ) nodal roots as affected by nitrogen and salinity.
  25. (1978). Electrophoretic analysis of alcohol dehydrogenase, aldehyde oxidase, sorbitol dehydrogenase and xanthine oxidase from mouse tissues.
  26. (1984). Elevation of molybdenum hydroxylase levels in rabbit liver after ingestion of pthalazine or its hydroxylatcd matabolite.
  27. (1999). Eukaryotic molybdenum synthase.
  28. (1995). Evidence for free-radical generation due to NADH oxidation by aldehyde oxidase during ethanolmetabolism.
  29. (1996). Expression of xanthine oxicloreductase in mouse mammary epithelium during pregnancy and lactation: Regulation of gene expression by glucocorticoids and prolactin.
  30. (1998). Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of CriglerNajjar syndrome type 1.
  31. (2000). Genetics of molybdenum cofactor deficiency.
  32. (1995). Hereditary xanthinuria. In "The Metabolic and Molecular Basis of Inherited Disease"
  33. (1989). Hereditary xanthinuria. In "The Metabolic Bases of Inherited Disease"
  34. (2001). Human xanthine dehydrogenase cDNA sequence and protein in an atypical case of type I xanthinuria in comparison with normal subjects.
  35. (2002). Identification and functional characterization of novel polymorphisms associated with the genes for arylarnine N- acatyltransferases in mice.
  36. (2001). Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type I xanthinuria.
  37. (2003). Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis ans retinoic acid homeostasis.
  38. (2001). Identification of novel SNPs in the coding and non coding regions of the xanthine dehydrogenase gene.
  39. Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria.
  40. (1999). In "Fundamentals of Biochemistry"
  41. (1982). In "Molecular cloning: A laboratory manual"
  42. (1997). In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver.
  43. (1997). Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium infection in mice.
  44. (2000). Insights into molybdenum cofactor deficiency provided by the crystal structure of the molybdenum cofactor biosynthesis protein MoaC.
  45. (2000). Inter-species variation in the metabolism and inhibition of N- [(2 ý-dimethylamino)ethyl]acridine-4-carboxamide (DACA) by aldehyde oxidase.
  46. (1995). Interindividual and interethnic differences in polymorphic drug oxidation. Implications for drug therapy with focus on psychoactive drugs.
  47. (1998). Isolation and characterization of the human aldehyde oxidase gene: conservation of intron/exon boundaries with the xanthine oxidoreductase gene indicates a common origin.
  48. (1998). Knockout animals in toxicology: assessment of toxin bioactivation pathways using mice deficient in xenobiotic metabolizing enzymes.
  49. (2001). Lack of UGTI isoforms in Gunn rats changes metabolic ratio and facilitates excretion of the food-derived carcinogen 2-amino- I -methyl-6-phenylimadazo[4,5-b]pyridine.
  50. (2003). Mammalian molybdo-flavoenzymcs, an expanding family of proteins: structure, genetics, rcgulation, function and pathophysiology.
  51. (2001). Marked elevation in cortical urate and xanthine oxidoreductase activity in experimental bacterial meningitis.
  52. (1992). Metabolic, molecular-genetic and toxicological aspects of the acetylation polymorphism in inbred mice.
  53. (1999). Metabolism of retinaldehyde and other aldehydes in soluble extracts of human liver and kidney.
  54. (1993). Metabolism of the experimental antitumor agent acridine carboxamide in the mouse. Drug Metab.
  55. (1984). Methode zur photometrisccn bestimming der aktivitat von aldehyoxydase.
  56. (1996). Molecular cloning and characterization of the human xanthine dehydrogenase gene (XDH).
  57. (2000). Molecular cloning and expression patterns of three putative functional aldehyde oxidase genes and isolation of two aldehyde oxidase pseudogenes in tomato.
  58. (2001). Molecular cloning of a cDNA coding for feline liver xanthine dehydrogenase.
  59. (1999). Molecular cloning of retinal oxidase aldehyde oxidase cDNAs from rabbit and mouse livers and functional expression of recombinant mouse retinal oxidase cDNA in Escherichia coli.
  60. (1997). Molecular cloning, refined chromosomal mapping and structural analysis of the human gene encoding aldehyde oxidase (AOXI), a candidate for the ALS2 gene.
  61. (1992). Molecular-cloning of a cDNA coding for mouse-liver xanthine dehydrogenase - regulation of its transcript by interferons in vivo.
  62. (1995). Molecular-cloning, tissue expression of human xanthine dehydrogenase (Vol 199, Pg 998,1994).
  63. (2003). Molybdenum cofactor-containing oxidoreductase family in plants.
  64. (1985). Molybdenum hydroxylases as drug metabolizing enzymes.
  65. (1987). Molybdenum hydroxylases: biological distribution and substrateinhibitor specificity.
  66. (1999). Molybdoenzymes and molybdenum cofactor in plants.
  67. (2001). Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type Il.
  68. (2003). Mutations in the molybdenum cofactor biosynthetic genes MOCSI,
  69. (2002). Novel disease-causing mutations in the dihydropyrimidine dehydrogenase gene interpreted by analysis of the three-dimentional protein structure.
  70. (2000). Nuclear factor Y activates the human xanthine oxidoreductase gene promoter.
  71. (1989). Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymerconjugated SOD.
  72. (1985). Oxygen-derived free radicals in postischernic tissue injury.
  73. (1972). Protein volume in solution.
  74. (1996). Purification and characterization of a prokaryotic xanthine dehydrogenase from Comamonas acidovorans.
  75. (1997). Purification and characterization of hepatic aldehyde oxidase in male and female mice.
  76. (2001). Purification of the aldehyde oxidase homologue I (AOH I) protein and cloning of the AOH I and aldehyde oxidase homologue 2 (AOH2) genes - Identification of a novel molybdo-flavoprotein gene cluster on mouse chromosome 1.
  77. (1996). Purification of the bovine xanthine oxidoreductase from milk fat globule membranes and cloning of complementary deoxyribonucleic acid.
  78. (1995). Purification, cDNA cloning, and tissue distribution of bovine liver aldehyde oxidase.
  79. (1993). Rat hepatocyte-mediated metabolism of the experimental anti-turnour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
  80. (1993). Retinal oxidase is identical to aldehyde oxidase.
  81. (1995). Role of aldehyde oxidase in the in-vitro conversion of famciclovir to penciclovir in human liver.
  82. (1996). Role of xanthine oxiclase and its inhibitor in hypoxia: Reoxygenation injury.
  83. (2000). Selective induction of cytochrome P450 3A I by dexamethasone in cultured rat hepatocytes.
  84. (1997). Selective localization of mouse aldehyde oxidase mRNA in the choroid plexus and motor neurons.
  85. (2000). Sequence motif-specific assignment of two [2Fe-2S] clusters in rat xanthine oxidoreductase studied by site-directed mutagenesis.
  86. (1995). Strain differences of liver aldehyde oxidase activity in rats.
  87. (1999). Strain differences of the ability to hydroxylate methotrexate in rats.
  88. (1999). Structure and expression of tandemly duplicated xanthine dehydrogenase genes of the silkwonn (Bombyx morz). Insect Mol.
  89. (2002). Structure and function of xanthine oxidoreductase: where are we now. Free Radic.
  90. (2000). The effects of allopurinol in hepatic ischernia and reperftision: Experimental study in rats.
  91. (2002). The housekeeping gene xanthine oxidoreductase is necessary for milk fat droplet enveloping and secretion: gene sharing in the lactating in the lactating manimary gland.
  92. (1995). The human gene for xanthine dehydrogcnase (Xdh) is localized on chromosome band 2p22.
  93. (1997). The human molybdenum hydroxylase gene family: co-conspirators in metabolic free-radical generation and disease.
  94. (1976). The mechanism of conversion of rat liver xanthine dehydrogenase from an NAD+ form (type D) to an 02 dependant form (type 0).
  95. (1999). The mouse aldehyde oxidase gene: Molecular cloning, chromosomal mapping and ftinctional characterization of the 5 '-flanking region.
  96. (1985). The phannacology and metabolism of the thiopurine drugs 6-mercaptopurine and azathiopurine.
  97. (1990). The role of aldehyde oxidase in ethanol-induced hepatic lipid- peroxidation in the rat.
  98. (1997). The role of non-P450 enzymes in drug oxidation.
  99. (2001). The sequence of the human genome.
  100. (1995). The structure of chicken liver xanthine dehydrogenase - cDNA cloning and the domain structure.
  101. (1999). Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8- hydroxy-thioguanine.
  102. (1987). Tissue distribution of the molybdenum hydroxylases, aldehyde oxidase and xanthinc-oxidase, in male and female guinea-pigs.
  103. (1994). Two different enzymes are primarily responsible for retinoic acid synthesis in rabbit liver cytosol.
  104. (2001). Understanding the role of xenobiotic-metabolism in chemical carcinogenesis using gene knockout mice.
  105. (1991). Use of Caffeine Metabolite Ratios to Explore Cyp I a2 and Xanthine-Oxidase Activities.
  106. (1997). Xanthine dehydrogenase and aldehyde oxidase. In "Comprehensive Toxicology,
  107. (2000). Xanthine dehydrogenase from leaves of leguminous plants: Purification, characterization and properties of the enzyme.
  108. (1998). Xanthine dehydrogenase from the phototrophic purple bacterium Rhodobacter capsulatus is more similar to its eukaryotic counterparts than to Prokaryotic molybdenum enzymes.
  109. (1995). Xanthine oxidase and xanthine dehydrogenase.
  110. (2000). Xanthine oxidase contributes to host defense against Burkholderia cepacia in the p47(phox-/-) mouse model of chronic granulomatous disease.
  111. (1986). Xanthine oxidase from human liver: Purification and characterization.
  112. (1954). Xanthinuria: an inbom error (or deviation) of metabolism.
  113. (2000). XDH gene mutation is the underlying cause of classical xanthinuria: A second report.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.